conservative strategy 110Ħ.2 Timing of angiography and intervention 110Ħ.3.1 Percutaneous coronary intervention 110Ħ.3.1.2 Revascularization strategies and outcomes 111Ħ.3.2 Coronary artery bypass grafting 111Ħ.3.3 Percutaneous coronary intervention vs. coronary artery bypass grafting 102ĥ.3.1.2 Anatomical complexity of coronary artery disease 104ĥ.3.1.3 Completeness of revascularization 106ĥ.3.2 Isolated proximal left anterior descending coronary artery disease 109ĥ.3.3 Left main coronary artery disease 109ĥ.3.4 Multivessel coronary artery disease 109Ħ Revascularization in non-ST-elevation acute coronary syndrome 110Ħ.1 Early invasive vs.

medical therapy in patients with coronary artery disease 97ģ.2.3 Use of fractional flow reserve and pressure-derived indices in patients with severe aortic stenosis 98ģ.2.4 Use of intravascular imaging for diagnostic assessment of stenosis 98Ĥ Process for decision-making and patient information 98Ĥ.1 Patient information and informed consent 98Ĥ.2 Multidisciplinary decision-making (Heart Team) 99ĥ Revascularization for stable coronary artery disease 101ĥ.2 Evidence basis for revascularization 101ĥ.2.1 Revascularization with the use of percutaneous coronary intervention 102ĥ.2.2 Revascularization with the use of coronary artery bypass grafting 102ĥ.3 Percutaneous coronary intervention vs. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS)ĭeveloped with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI) Table of contentsĢ.1 What is new in the 2018 Guidelines? 95ģ Diagnostic tools to guide myocardial revascularization 96ģ.1.1 Assessment of myocardial ischaemia 96ģ.1.2 Assessment of myocardial viability in patients with heart failure and coronary artery disease 96ģ.2.1 Pressure-derived fractional flow reserve 96ģ.2.1.1 Use of fractional flow reserve in patients with intermediate-grade coronary stenosis including left main stenosis 96ģ.2.1.2 Use of fractional flow reserve to identify lesions requiring revascularization in patients with multivessel coronary artery disease undergoing percutaneous coronary intervention 97ģ.2.1.3 Fractional flow reserve-guided management vs.

Acute coronary syndromes, Antithrombotic therapy, Bare-metal stents, Coronary artery bypass grafting, Coronary artery disease, Drug-eluting stents, Guidelines, Heart Team, Myocardial infarction, Myocardial ischaemia, Myocardial revascularization, Medical therapy, Percutaneous coronary intervention, Recommendation, Revascularization, Risk stratification, Stents, Stable angina, Stable coronary artery disease, ST-segment elevation myocardial infarction, SYNTAX score

Whats a guideliner interventional